{
    "clinical_study": {
        "@rank": "1737", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine\n      release."
        }, 
        "brief_title": "Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11", 
        "condition": [
            "Cocaine-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cocaine-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective of this study is to evaluate PET methodology to study in vivo synaptic\n      dopamine release."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy normals\n\n        Exclusion Criteria:\n\n        History of head trauma or loss of consciousness. Significant medical history. History of\n        seizures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "April 18, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00015301", 
            "org_study_id": "NIDA-5-0013-11", 
            "secondary_id": "Y01-5-0013-11"
        }, 
        "intervention": {
            "intervention_name": "Methylphenidate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Methylphenidate", 
                "Raclopride"
            ]
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10010"
                }, 
                "name": "New York MDRU"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Methylphenidate Raclopride PET Test", 
        "overall_official": {
            "affiliation": "New York MDRU", 
            "last_name": "John Rotrosen, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "primary_outcome": {
            "measure": "Dopamine receptor availability"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00015301"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "New York MDRU", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Masking: Double-Blind, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "New York MDRU": "40.714 -74.006"
    }
}